Enrolment flow chart of RR-TB patients.

Cascade of care and time to diagnosis and treatment of Xpert rifampicin-resistant TB patients.

Arto Yuwono Soeroto (6411806)
Bony Wiem Lestari (6411809)
Prayudi Santoso (6411812)
Lidya Chaidir (103945)
Basti Andriyoko (6411815)
Bachti Alisjahbana (270243)
Reinout van Crevel (60606)
Philip C. Hill (20648)

February 2019

Values in the bars indicate number (percentages). *12 of 118 with a failed result were imputed as Xp...

Treatment algorithm by resistance status.

Gesine Meyer-Rath (144675)
Kathryn Schnippel (320845)
Lawrence Long (320846)
William MacLeod (320847)
Ian Sanne (170641)
Wendy Stevens (62288)
Sagie Pillay (320848)
Yogan Pillay (320849)
Sydney Rosen (213204)

February 2013

R denotes rifampicin, H, isoniazid, Z, pyrazinamide, E, ethambutol, S, streptomycin, OFX, ofloxac...

Treatment outcomes among tuberculosis (TB) patients with simple MDR TB, pre-XDR TB and XDR TB, stratified by new cases versus previously treated cases.

Ming Zhao (48501)
Xia Li (14984)
Peng Xu (17962)
Xin Shen (108948)
Xiaohong Gui (374693)
Lili Wang (104605)
Kathryn DeRiemer (296551)
Jian Mei (160558)
Qian Gao (146991)

February 2013

OR = odds ratio.CI = confidence interval.MDR = resistance to at least isoniazid and...

Patient flow diagram for study participants.

Tushar Garg (9283574)
Bareng Aletta Sanny Nonyane (3738811)
Mbali Mohlamonyane (16827914)
Limakatso Lebina (554886)
Neil A. Martinson (8587299)
David W. Dowdy (8964830)
Colleen F. Hanrahan (9623503)

August 2023

The patient flow diagram represents the cohort of people diagnosed with drug-sensitive TB at each st...

Flow diagram showing initial specimens from NHLS, person-linkage results in unique individuals, reasons for exclusion from final mapping, and final results stratified by number of tuberculosis episodes and number of individuals with RR-tuberculosis.

Avery I. McIntosh (5662172)
Helen E. Jenkins (307031)
Laura F. White (298306)
Marinus Barnard (359844)
Dana R. Thomson (496122)
Tania Dolby (5662175)
John Simpson (359843)
Elizabeth M. Streicher (439727)
Mary B. Kleinman (5662178)
Elizabeth J. Ragan (5662181)
Paul D. van Helden (33594)
Megan B. Murray (222921)
Robin M. Warren (33593)
Karen R. Jacobson (497399)

August 2018

*Locations of individuals with no specimens submitted from a clinic, indicating the location of the ...

Flow-diagram showing inclusion criteria and outcomes of 100 eligible patients.

Dominique J. Pepper (221049)
Suzaan Marais (221045)
Robert J. Wilkinson (130050)
Feriyl Bhaijee (318838)
Virginia De Azevedo (129372)
Graeme Meintjes (221054)

February 2013

ART: antiretroviral treatment, TB: tuberculosis, WHO: World Health Or...

2012 cohort; MDR TB treatment

Seung, KJ

All patients enrolled in MDR-TB treatment in 2012 with a diagnosis of rifampicin resistance

Study population, 1993–2007.

Lisa Pascopella (340630)
Kathryn DeRiemer (296551)
James P. Watt (340632)
Jennifer M. Flood (340635)

February 2013

The figure shows the classification of patients in the study and the inclusion criteria. TB patie...

Inclusion of patients in the analysis.

Courtney M. Yuen (501740)
Ekaterina V. Kurbatova (300259)
Thelma Tupasi (841503)
Janice Campos Caoili (841504)
Martie Van Der Walt (5666335)
Charlotte Kvasnovsky (841505)
Martin Yagui (549966)
Jaime Bayona (94958)
Carmen Contreras (460645)
Vaira Leimane (139482)
Julia Ershova (841506)
Laura E. Via (315019)
HeeJin Kim (841507)
Somsak Akksilp (371572)
Boris Y. Kazennyy (841508)
Grigory V. Volchenkov (841509)
Ruwen Jou (486507)
Kai Kliiman (841510)
Olga V. Demikhova (841511)
Irina A. Vasilyeva (142018)
Tracy Dalton (841512)
J. Peter Cegielski (300261)

January 2016

MDR-TB is tuberculosis resistant to at least isoniazid and rifampin; XDR-TB is tuberculosis resis...

Baseline demographic and clinical characteristics of DR-TB patients at enrolment (n = 333) and of patients included in 12 month interim outcomes analysis (n = 240).

Kamban Hirasen (3331569)
Rebecca Berhanu (442834)
Denise Evans (288201)
Sydney Rosen (213204)
Ian Sanne (170641)
Lawrence Long (320846)

October 2018

Baseline demographic and clinical characteristics of DR-TB patients at enrolment (n = 333) and of pa...

TB and rifampicin resistant-TB cases detected and initiated on treatment by each of the 4 diagnostic strategies, in a cohort 100,000 persons.

Sunil Khaparde (4419847)
Neeraj Raizada (52447)
Sreenivas Achuthan Nair (295840)
Claudia Denkinger (308888)
Kuldeep Singh Sachdeva (305148)
Chinnambedu Nainarappan Paramasivan (763725)
Virender Singh Salhotra (4419841)
Anna Vassall (144677)
Anja van't Hoog (4419844)

September 2017

TB and rifampicin resistant-TB cases detected and initiated on treatment by each of the 4 diagnos...

Predictors of mortality and treatment success during treatment for rifampicin-resistant tuberculosis within the South African National TB Programme, 2009 to 2011: a cohort analysis of the national case register

Schnippel, Kathryn
Shearer, Kate
Evans, Denise
Berhanu, Rebecca
Dlamini, S’celo
Ndjeka, Norbert

October 2015

SummaryBackgroundThe South African Electronic Drug-Resistant Tuberculosis Register (EDRweb) is the n...

Predictors of mortality and treatment success during treatment for rifampicin-resistant tuberculosis within the South African National TB Programme, 2009 to 2011: a cohort analysis of the national case register

Kathryn Schnippel
Kate Shearer
Denise Evans
Rebecca Berhanu
S’celo Dlamini
Norbert Ndjeka

October 2015

Background: The South African Electronic Drug-Resistant Tuberculosis Register (EDRweb) is the nation...

Flow of cohort study participants.

Brian Lackey (750436)
Carlos Seas (308510)
Patrick Van der Stuyft (154687)
Larissa Otero (308500)

June 2015

We initially enrolled 1294 pulmonary, smear-positive tuberculosis patients into the study. One pa...

Flow chart showing treatment initiation cascade stratified by CBMDR-TBC status among diagnosed MDR-TB patients in 33 CBMDR-TBC project supported townships of upper Myanmar, January 2015-June 2016.

Pyae Phyo Wai (4707409)
Hemant Deepak Shewade (760494)
Nang Thu Thu Kyaw (786600)
Saw Thein (4707421)
Aung Si Thu (4707418)
Khine Wut Yee Kyaw (3737635)
Nyein Nyein Aye (5040137)
Aye Mon Phyo (5040134)
Htet Myet Win Maung (4707415)
Kyaw Thu Soe (4707412)
Si Thu Aung (4707427)

March 2018

*MDR-TB: Multi drug resistant tuberculosis. aPatient considered receiving support if d...

Cascade of care and time to diagnosis and treatment of Xpert rifampicin-resistant TB patients.

Arto Yuwono Soeroto (6411806)
Bony Wiem Lestari (6411809)
Prayudi Santoso (6411812)
Lidya Chaidir (103945)
Basti Andriyoko (6411815)
Bachti Alisjahbana (270243)
Reinout van Crevel (60606)
Philip C. Hill (20648)

February 2019

Values in the bars indicate number (percentages). *12 of 118 with a failed result were imputed as Xp...

Treatment algorithm by resistance status.

Gesine Meyer-Rath (144675)
Kathryn Schnippel (320845)
Lawrence Long (320846)
William MacLeod (320847)
Ian Sanne (170641)
Wendy Stevens (62288)
Sagie Pillay (320848)
Yogan Pillay (320849)
Sydney Rosen (213204)

February 2013

R denotes rifampicin, H, isoniazid, Z, pyrazinamide, E, ethambutol, S, streptomycin, OFX, ofloxac...

Treatment outcomes among tuberculosis (TB) patients with simple MDR TB, pre-XDR TB and XDR TB, stratified by new cases versus previously treated cases.

Ming Zhao (48501)
Xia Li (14984)
Peng Xu (17962)
Xin Shen (108948)
Xiaohong Gui (374693)
Lili Wang (104605)
Kathryn DeRiemer (296551)
Jian Mei (160558)
Qian Gao (146991)

February 2013

OR = odds ratio.CI = confidence interval.MDR = resistance to at least isoniazid and...

Patient flow diagram for study participants.

Tushar Garg (9283574)
Bareng Aletta Sanny Nonyane (3738811)
Mbali Mohlamonyane (16827914)
Limakatso Lebina (554886)
Neil A. Martinson (8587299)
David W. Dowdy (8964830)
Colleen F. Hanrahan (9623503)

August 2023

The patient flow diagram represents the cohort of people diagnosed with drug-sensitive TB at each st...

Flow diagram showing initial specimens from NHLS, person-linkage results in unique individuals, reasons for exclusion from final mapping, and final results stratified by number of tuberculosis episodes and number of individuals with RR-tuberculosis.

Avery I. McIntosh (5662172)
Helen E. Jenkins (307031)
Laura F. White (298306)
Marinus Barnard (359844)
Dana R. Thomson (496122)
Tania Dolby (5662175)
John Simpson (359843)
Elizabeth M. Streicher (439727)
Mary B. Kleinman (5662178)
Elizabeth J. Ragan (5662181)
Paul D. van Helden (33594)
Megan B. Murray (222921)
Robin M. Warren (33593)
Karen R. Jacobson (497399)

August 2018

*Locations of individuals with no specimens submitted from a clinic, indicating the location of the ...

Flow-diagram showing inclusion criteria and outcomes of 100 eligible patients.

Dominique J. Pepper (221049)
Suzaan Marais (221045)
Robert J. Wilkinson (130050)
Feriyl Bhaijee (318838)
Virginia De Azevedo (129372)
Graeme Meintjes (221054)

February 2013

ART: antiretroviral treatment, TB: tuberculosis, WHO: World Health Or...

2012 cohort; MDR TB treatment

Seung, KJ

All patients enrolled in MDR-TB treatment in 2012 with a diagnosis of rifampicin resistance

Study population, 1993–2007.

Lisa Pascopella (340630)
Kathryn DeRiemer (296551)
James P. Watt (340632)
Jennifer M. Flood (340635)

February 2013

The figure shows the classification of patients in the study and the inclusion criteria. TB patie...

Inclusion of patients in the analysis.

Courtney M. Yuen (501740)
Ekaterina V. Kurbatova (300259)
Thelma Tupasi (841503)
Janice Campos Caoili (841504)
Martie Van Der Walt (5666335)
Charlotte Kvasnovsky (841505)
Martin Yagui (549966)
Jaime Bayona (94958)
Carmen Contreras (460645)
Vaira Leimane (139482)
Julia Ershova (841506)
Laura E. Via (315019)
HeeJin Kim (841507)
Somsak Akksilp (371572)
Boris Y. Kazennyy (841508)
Grigory V. Volchenkov (841509)
Ruwen Jou (486507)
Kai Kliiman (841510)
Olga V. Demikhova (841511)
Irina A. Vasilyeva (142018)
Tracy Dalton (841512)
J. Peter Cegielski (300261)

January 2016

MDR-TB is tuberculosis resistant to at least isoniazid and rifampin; XDR-TB is tuberculosis resis...

Baseline demographic and clinical characteristics of DR-TB patients at enrolment (n = 333) and of patients included in 12 month interim outcomes analysis (n = 240).

Kamban Hirasen (3331569)
Rebecca Berhanu (442834)
Denise Evans (288201)
Sydney Rosen (213204)
Ian Sanne (170641)
Lawrence Long (320846)

October 2018

Baseline demographic and clinical characteristics of DR-TB patients at enrolment (n = 333) and of pa...

TB and rifampicin resistant-TB cases detected and initiated on treatment by each of the 4 diagnostic strategies, in a cohort 100,000 persons.

Sunil Khaparde (4419847)
Neeraj Raizada (52447)
Sreenivas Achuthan Nair (295840)
Claudia Denkinger (308888)
Kuldeep Singh Sachdeva (305148)
Chinnambedu Nainarappan Paramasivan (763725)
Virender Singh Salhotra (4419841)
Anna Vassall (144677)
Anja van't Hoog (4419844)

September 2017

TB and rifampicin resistant-TB cases detected and initiated on treatment by each of the 4 diagnos...

Predictors of mortality and treatment success during treatment for rifampicin-resistant tuberculosis within the South African National TB Programme, 2009 to 2011: a cohort analysis of the national case register

Schnippel, Kathryn
Shearer, Kate
Evans, Denise
Berhanu, Rebecca
Dlamini, S’celo
Ndjeka, Norbert

October 2015

SummaryBackgroundThe South African Electronic Drug-Resistant Tuberculosis Register (EDRweb) is the n...

Predictors of mortality and treatment success during treatment for rifampicin-resistant tuberculosis within the South African National TB Programme, 2009 to 2011: a cohort analysis of the national case register

Kathryn Schnippel
Kate Shearer
Denise Evans
Rebecca Berhanu
S’celo Dlamini
Norbert Ndjeka

October 2015

Background: The South African Electronic Drug-Resistant Tuberculosis Register (EDRweb) is the nation...

Flow of cohort study participants.

Brian Lackey (750436)
Carlos Seas (308510)
Patrick Van der Stuyft (154687)
Larissa Otero (308500)

June 2015

We initially enrolled 1294 pulmonary, smear-positive tuberculosis patients into the study. One pa...

Flow chart showing treatment initiation cascade stratified by CBMDR-TBC status among diagnosed MDR-TB patients in 33 CBMDR-TBC project supported townships of upper Myanmar, January 2015-June 2016.

Pyae Phyo Wai (4707409)
Hemant Deepak Shewade (760494)
Nang Thu Thu Kyaw (786600)
Saw Thein (4707421)
Aung Si Thu (4707418)
Khine Wut Yee Kyaw (3737635)
Nyein Nyein Aye (5040137)
Aye Mon Phyo (5040134)
Htet Myet Win Maung (4707415)
Kyaw Thu Soe (4707412)
Si Thu Aung (4707427)

March 2018

*MDR-TB: Multi drug resistant tuberculosis. aPatient considered receiving support if d...

Cascade of care and time to diagnosis and treatment of Xpert rifampicin-resistant TB patients.

Arto Yuwono Soeroto (6411806)
Bony Wiem Lestari (6411809)
Prayudi Santoso (6411812)
Lidya Chaidir (103945)
Basti Andriyoko (6411815)
Bachti Alisjahbana (270243)
Reinout van Crevel (60606)
Philip C. Hill (20648)

February 2019

Values in the bars indicate number (percentages). *12 of 118 with a failed result were imputed as Xp...

Treatment algorithm by resistance status.

Gesine Meyer-Rath (144675)
Kathryn Schnippel (320845)
Lawrence Long (320846)
William MacLeod (320847)
Ian Sanne (170641)
Wendy Stevens (62288)
Sagie Pillay (320848)
Yogan Pillay (320849)
Sydney Rosen (213204)

February 2013

R denotes rifampicin, H, isoniazid, Z, pyrazinamide, E, ethambutol, S, streptomycin, OFX, ofloxac...

Treatment outcomes among tuberculosis (TB) patients with simple MDR TB, pre-XDR TB and XDR TB, stratified by new cases versus previously treated cases.

Ming Zhao (48501)
Xia Li (14984)
Peng Xu (17962)
Xin Shen (108948)
Xiaohong Gui (374693)
Lili Wang (104605)
Kathryn DeRiemer (296551)
Jian Mei (160558)
Qian Gao (146991)

February 2013

OR = odds ratio.CI = confidence interval.MDR = resistance to at least isoniazid and...

Enrolment flow chart of RR-TB patients.

Abstract

Extracted data

Enrolment flow chart of RR-TB patients.

Abstract

Extracted data

Related items

Related items